{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T19:26:41Z","timestamp":1748114801216},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,10]]},"DOI":"10.7759\/cureus.24013","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T17:17:16Z","timestamp":1649611036000},"source":"Crossref","is-referenced-by-count":4,"title":["Estimation of Serum Ferritin in Mucormycosis Patients and Prognostication Based on the Ferritin Value"],"prefix":"10.7759","author":[{"given":"Babu","family":"Anand C","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivasubramaniyam","family":"Senthilkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedha","family":"P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Ibrahim C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khizer Hussain","family":"Afroze M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramanathan","family":"M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim AS","year":"2008","unstructured":"Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008, 21:620-5. 10.1097\/QCO.0b013e3283165fd1","journal-title":"Curr Opin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.48.3.223","article-title":"Iron metabolism and fungal infections in patients with haematological malignancies","volume":"48","author":"Iglesias-Osma C","year":"1995","unstructured":"Iglesias-Osma C, Gonzalez-Villaron L, San Miguel JF, Caballero MD, Vazquez L, de Castro S. Iron metabolism and fungal infections in patients with haematological malignancies. J Clin Pathol. 1995, 48:223-5. 10.1136\/jcp.48.3.223","journal-title":"J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2021\/703","article-title":"Radiological imaging findings of rhino-orbito-cerebral mucormycosis in COVID and post-COVID patients--a descriptive study of 200 patients","volume":"10","author":"Usmani Y","year":"2021","unstructured":"Usmani Y, Shukla B, Kumar S, Dubey M, Asif M. Radiological imaging findings of rhino-orbito-cerebral mucormycosis in COVID and post-COVID patients--a descriptive study of 200 patients. J Evol Med Dent Sci. 2021, 10:3470-4. 10.14260\/jemds\/2021\/703","journal-title":"J Evol Med Dent Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicenter observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel A","year":"2020","unstructured":"Patel A, Kaur H, Xess I, et al.. A multicenter observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020, 26:944.e9-944.e15. 10.1016\/j.cmi.2019.11.021","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada A","year":"2011","unstructured":"Skiada A, Pagano L, Groll A, et al.. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011, 17:1859-67. 10.1111\/j.1469-0691.2010.03456.x","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali A","year":"2004","unstructured":"Bhansali A, Bhadada S, Sharma A, et al.. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004, 80:670-4. 10.1136\/pgmj.2003.016030","journal-title":"Postgrad Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India","volume":"15","author":"Mishra Y","year":"2021","unstructured":"Mishra Y, Prashar M, Sharma D, Akash, Kumar VP, Tilak TV. Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr. 2021, 15:102196. 10.1016\/j.dsx.2021.102196","journal-title":"Diabetes Metab Syndr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/13693780903311944","article-title":"Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases","volume":"48","author":"Shoham S","year":"2010","unstructured":"Shoham S, Magill SS, Merz WG, et al.. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Med Mycol. 2010, 48:511-7. 10.3109\/13693780903311944","journal-title":"Med Mycol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.669502","article-title":"Risk factors for mortality in patients with mucormycosis","volume":"50","author":"Spellberg B","year":"2012","unstructured":"Spellberg B, Kontoyiannis DP, Fredricks D, et al.. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012, 50:611-8. 10.3109\/13693786.2012.669502","journal-title":"Med Mycol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709578105","article-title":"Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis","volume":"105","author":"Chamilos G","year":"2008","unstructured":"Chamilos G, Lewis RE, Hu J, et al.. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A. 2008, 105:9367-72. 10.1073\/pnas.0709578105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim AS","year":"2007","unstructured":"Ibrahim AS, Gebermariam T, Fu Y, et al.. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007, 117:2649-57. 10.1172\/JCI32338","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis","volume":"77","author":"Ibrahim AS","year":"2010","unstructured":"Ibrahim AS, Gebremariam T, Lin L, et al.. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. 2010, 77:587-604. 10.1111\/j.1365-2958.2010.07234.x","journal-title":"Mol Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg B","year":"2005","unstructured":"Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005, 18:556-69. 10.1128\/CMR.18.3.556-569.2005","journal-title":"Clin Microbiol Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01604-2","article-title":"Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review","volume":"20","author":"Jose A","year":"2021","unstructured":"Jose A, Singh S, Roychoudhury A, Kholakiya Y, Arya S, Roychoudhury S. Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review. J Maxillofac Oral Surg. 2021, 20:373-80. 10.1007\/s12663-021-01604-2","journal-title":"J Maxillofac Oral Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2019.11.006","article-title":"Neutrophil, lymphocyte and platelet ratio as a predictor of mortality in septic-acute kidney injury patients","volume":"40","author":"Gameiro J","year":"2020","unstructured":"Gameiro J, Fonseca JA, Jorge S, Gouveia J, Lopes JA. Neutrophil, lymphocyte and platelet ratio as a predictor of mortality in septic-acute kidney injury patients. Nefrologia (Engl Ed). 2020, 40:461-8. 10.1016\/j.nefro.2019.11.006","journal-title":"Nefrologia (Engl Ed)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1073-4","article-title":"Neutrophil, lymphocyte and platelet ratio as a predictor of postoperative acute kidney injury in major abdominal surgery","volume":"19","author":"Gameiro J","year":"2018","unstructured":"Gameiro J, Fonseca JA, Dias JM, Milho J, Rosa R, Jorge S, Lopes JA. Neutrophil, lymphocyte and platelet ratio as a predictor of postoperative acute kidney injury in major abdominal surgery. BMC Nephrol. 2018, 19:320. 10.1186\/s12882-018-1073-4","journal-title":"BMC Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2017.08.033","article-title":"Neutrophil, lymphocyte, and platelet counts and acute kidney injury after cardiovascular surgery","volume":"32","author":"Koo CH","year":"2018","unstructured":"Koo CH, Eun Jung D, Park YS, Bae J, Cho YJ, Kim WH, Bahk JH. Neutrophil, lymphocyte, and platelet counts and acute kidney injury after cardiovascular surgery. J Cardiothorac Vasc Anesth. 2018, 32:212-22. 10.1053\/j.jvca.2017.08.033","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5222\/MMJ.2021.95676","article-title":"Evaluation of N\/LP ratio as a predictor of disease progression and mortality in COVID-19 patients admitted to the intensive care unit","volume":"36","author":"Guney BC","year":"2021","unstructured":"Guney BC, Hayiroglu M, Senocak D, C\u0130cek V, Cinar T, Kaplan M. Evaluation of N\/LP ratio as a predictor of disease progression and mortality in COVID-19 patients admitted to the intensive care unit. Medeni Med J. 2021, 36:241-8. 10.5222\/MMJ.2021.95676","journal-title":"Medeni Med J"},{"key":"ref21","article-title":"The FET4 gene encodes the low affinity Fe(II) transport protein of Saccharomyces cerevisiae","volume":"269","author":"Dix DR","year":"1994","unstructured":"Dix DR, Bridgham JT, Broderius MA, Byersdorfer CA, Eide DJ. The FET4 gene encodes the low affinity Fe(II) transport protein of Saccharomyces cerevisiae. J Biol Chem. 1994, 269:26092-9.","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-145-9-2415","article-title":"A multicopper oxidase gene from Candida albicans: cloning, characterization and disruption","volume":"145","author":"Eck R","year":"1999","unstructured":"Eck R, Hundt S, H\u00e4rtl A, Roemer E, K\u00fcnkel W. A multicopper oxidase gene from Candida albicans: cloning, characterization and disruption. Microbiology (Reading). 1999, 145:2415-22. 10.1099\/00221287-145-9-2415","journal-title":"Microbiology (Reading)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-148-1-29","article-title":"Reductive iron uptake by Candida albicans: role of copper, iron and the TUP1 regulator","volume":"148","author":"Knight SA","year":"2002","unstructured":"Knight SA, Lesuisse E, Stearman R, Klausner RD, Dancis A. Reductive iron uptake by Candida albicans: role of copper, iron and the TUP1 regulator. Microbiology (Reading). 2002, 148:29-40. 10.1099\/00221287-148-1-29","journal-title":"Microbiology (Reading)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5468.1062","article-title":"A high-affinity iron permease essential for Candida albicans virulence","volume":"288","author":"Ramanan N","year":"2000","unstructured":"Ramanan N, Wang Y. A high-affinity iron permease essential for Candida albicans virulence. Science. 2000, 288:1062-4. 10.1126\/science.288.5468.1062","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/yea.840","article-title":"Siderophore uptake by Candida albicans: effect of serum treatment and comparison with Saccharomyces cerevisiae","volume":"19","author":"Lesuisse E","year":"2002","unstructured":"Lesuisse E, Knight SA, Camadro JM, Dancis A. Siderophore uptake by Candida albicans: effect of serum treatment and comparison with Saccharomyces cerevisiae. Yeast. 2002, 19:329-40. 10.1002\/yea.840","journal-title":"Yeast"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-12-3455","article-title":"Siderophore-mediated iron uptake in Saccharomyces cerevisiae: the SIT1 gene encodes a ferrioxamine B permease that belongs to the major facilitator superfamily","volume":"144","author":"Lesuisse E","year":"1998","unstructured":"Lesuisse E, Simon-Casteras M, Labbe P. Siderophore-mediated iron uptake in Saccharomyces cerevisiae: the SIT1 gene encodes a ferrioxamine B permease that belongs to the major facilitator superfamily. Microbiology (Reading). 1998, 144:3455-62. 10.1099\/00221287-144-12-3455","journal-title":"Microbiology (Reading)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.5246-5255.2002","article-title":"The siderophore iron transporter of Candida albicans (Sit1p\/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion","volume":"70","author":"Heymann P","year":"2002","unstructured":"Heymann P, Gerads M, Schaller M, Dromer F, Winkelmann G, Ernst JF. The siderophore iron transporter of Candida albicans (Sit1p\/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun. 2002, 70:5246-55. 10.1128\/IAI.70.9.5246-5255.2002","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.26108-0","article-title":"Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase","volume":"149","author":"Santos R","year":"2003","unstructured":"Santos R, Buisson N, Knight S, Dancis A, Camadro JM, Lesuisse E. Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase. Microbiology (Reading). 2003, 149:579-88. 10.1099\/mic.0.26108-0","journal-title":"Microbiology (Reading)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001343","article-title":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes","volume":"8","author":"Yan Y","year":"2020","unstructured":"Yan Y, Yang Y,Wang F, et al.. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020, 8:e001343. 10.1136\/bmjdrc-2020-001343","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23618","article-title":"Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"34","author":"Cheng L","year":"2020","unstructured":"Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Lab Anal. 2020, 34:e23618. 10.1002\/jcla.23618","journal-title":"J Clin Lab Anal"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.08.037","article-title":"Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic","volume":"111","author":"Bhanuprasad K","year":"2021","unstructured":"Bhanuprasad K, Manesh A, Devasagayam E, et al.. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic. Int J Infect Dis. 2021, 111:267-70. 10.1016\/j.ijid.2021.08.037","journal-title":"Int J Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20569","article-title":"Hyperferritinemia and the extent of mucormycosis in COVID-19 patients","volume":"13","author":"Bhadania S","year":"2021","unstructured":"Bhadania S, Bhalodiya N, Sethi Y, et al.. Hyperferritinemia and the extent of mucormycosis in COVID-19 patients. Cureus. 2021, 13:e20569. 10.7759\/cureus.20569","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102573","article-title":"COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome?","volume":"19","author":"Colafrancesco S","year":"2020","unstructured":"Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome?. Autoimmun Rev. 2020, 19:102573. 10.1016\/j.autrev.2020.102573","journal-title":"Autoimmun Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1039\/c4ib00025k","article-title":"Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases","volume":"6","author":"Pretorius E","year":"2014","unstructured":"Pretorius E, Kell DB. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr Biol (Camb). 2014, 6:486-510. 10.1039\/c4ib00025k","journal-title":"Integr Biol (Camb)"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ehsani S. Distant Sequence Similarity Between Hepcidin and the Novel Coronavirus Spike Glycoprotein. A Potential Hint at the Possibility of Local Iron Dysregulation in COVID-19. (2020). Accessed: March 27, 2020: https:\/\/www.researchgate.net\/publication\/340271362_Distant_sequence_similarity_between_hepcidin_and_the_novel_coronav....","DOI":"10.1186\/s13062-020-00275-2"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91702-estimation-of-serum-ferritin-in-mucormycosis-patients-and-prognostication-based-on-the-ferritin-value","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:16Z","timestamp":1707507496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91702-estimation-of-serum-ferritin-in-mucormycosis-patients-and-prognostication-based-on-the-ferritin-value"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,10]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.24013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,10]]}}}